Document is current
Any future updates will be listed below
-
Authors
Warkentin, Lisette http://orcid.org/0000-0002-6241-6082
Zeschick, Nikoletta http://orcid.org/0000-0001-8773-3618
Kühlein, Thomas
Steininger, Philipp
Überla, Klaus
Kaiser, Isabelle
Gall, Christine
Sebastião, Maria
Hueber, Susann http://orcid.org/0000-0003-0844-0919
-
Funding
Funding for this research was provided by:
Bayerisches Staatsministerium für Wissenschaft, Forschung und Kunst (152821006, 152821006, 152821006, 152821006, 152821006, 152821006, 152821006, 152821006, 152821006)
Friedrich-Alexander-Universität Erlangen-Nürnberg
- License Information
-
More Information
Article History
Received: 26 November 2021
Accepted: 4 May 2022
First Online: 31 May 2022
Declarations
:
: The Ethics Committee of the Friedrich-Alexander University approved the study (47_21 B, 01.03.2021 and 161_21 B, 12.05.2021). The reporting of the study is based on the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) recommendations. All participants gave their informed consent.
: Not applicable.
: LW, NZ own(ed) stocks of BioNTech, the investments were made before being involved in the project. The authors declare that they have no further competing interests.
